These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19106034)

  • 61. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
    Knott VJ; Fisher DJ; Millar AM
    Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.
    Hsieh MH; Shan JC; Huang WL; Cheng WC; Chiu MJ; Jaw FS; Hwu HG; Liu CC
    Schizophr Res; 2012 Sep; 140(1-3):243-9. PubMed ID: 22784684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
    Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
    Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Normal P50 Gating in Children with Autism, Yet Attenuated P50 Amplitude in the Asperger Subcategory.
    Madsen GF; Bilenberg N; Jepsen JR; Glenthøj B; Cantio C; Oranje B
    Autism Res; 2015 Aug; 8(4):371-8. PubMed ID: 25599888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of metabolic syndrome with sensory gating deficits in patients with chronic schizophrenia.
    Micoulaud-Franchi JA; Faugere M; Boyer L; Cermolacce M; Richieri R; Faget C; Philip P; Vion-Dury J; Lancon C
    Psychoneuroendocrinology; 2015 Jul; 57():125-33. PubMed ID: 25917886
    [TBL] [Abstract][Full Text] [Related]  

  • 66. M50 sensory gating predicts negative symptoms in schizophrenia.
    Thoma RJ; Hanlon FM; Moses SN; Ricker D; Huang M; Edgar C; Irwin J; Torres F; Weisend MP; Adler LE; Miller GA; Canive JM
    Schizophr Res; 2005 Mar; 73(2-3):311-8. PubMed ID: 15653276
    [TBL] [Abstract][Full Text] [Related]  

  • 67. P50-N100-P200 sensory gating deficits in adolescents and young adults with autism spectrum disorders.
    Chien YL; Hsieh MH; Gau SS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109683. PubMed ID: 31260720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sex differences in P50 inhibition defects with psychopathology and cognition in patients with first-episode schizophrenia.
    Xia L; Liu R; Zhou H; Tian Y; Dai Q; Xiu M; Chen D; Wang D; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110380. PubMed ID: 34111493
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Failure to find P50 suppression deficits in young first-episode patients with schizophrenia and clinically unaffected siblings.
    de Wilde OM; Bour LJ; Dingemans PM; Koelman JH; Linszen DH
    Schizophr Bull; 2007 Nov; 33(6):1319-23. PubMed ID: 17289652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Auditory sensory processing deficits in sensory gating and mismatch negativity-like responses in the social isolation rat model of schizophrenia.
    Witten L; Oranje B; Mørk A; Steiniger-Brach B; Glenthøj BY; Bastlund JF
    Behav Brain Res; 2014 Jun; 266():85-93. PubMed ID: 24613239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationships between sensory "gating out" and sensory "gating in" of auditory evoked potentials in schizophrenia: a pilot study.
    Gjini K; Arfken C; Boutros NN
    Schizophr Res; 2010 Aug; 121(1-3):139-45. PubMed ID: 20537865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lateralization of auditory sensory gating and neuropsychological dysfunction in schizophrenia.
    Thoma RJ; Hanlon FM; Moses SN; Edgar JC; Huang M; Weisend MP; Irwin J; Sherwood A; Paulson K; Bustillo J; Adler LE; Miller GA; Cañive JM
    Am J Psychiatry; 2003 Sep; 160(9):1595-605. PubMed ID: 12944333
    [TBL] [Abstract][Full Text] [Related]  

  • 74. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment.
    Cadenhead KS; Light GA; Shafer KM; Braff DL
    Biol Psychiatry; 2005 Jun; 57(12):1504-9. PubMed ID: 15953486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. P50 sensory gating and smoking in the general population.
    Brinkmeyer J; Mobascher A; Musso F; Schmitz M; Wagner M; Frommann I; Gründer G; Spreckelmeyer KN; Wienker T; Díaz-Lacava A; Holler D; Dahmen N; Thuerauf N; Clepce M; Kiefer F; de Millas W; Gallinat J; Winterer G
    Addict Biol; 2011 Jul; 16(3):485-98. PubMed ID: 21392171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Filtering out repetitive auditory stimuli in fibromyalgia: a study of P50 sensory gating.
    Carrillo-de-la-Peña MT; Triñanes Y; González-Villar A; Gómez-Perretta C; García-Larrea L
    Eur J Pain; 2015 Apr; 19(4):576-84. PubMed ID: 25430500
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.
    Freedman R; Adler LE; Waldo MC; Pachtman E; Franks RD
    Biol Psychiatry; 1983 May; 18(5):537-51. PubMed ID: 6134559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.
    Oranje B; Wienberg M; Glenthoj BY
    Psychiatry Res; 2011 Apr; 186(2-3):431-6. PubMed ID: 20971512
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The P50 auditory evoked potential in violent and non-violent patients with schizophrenia.
    Fresán A; Apiquian R; García-Anaya M; de la Fuente-Sandoval C; Nicolini H; Graff-Guerrero A
    Schizophr Res; 2007 Dec; 97(1-3):128-36. PubMed ID: 17936591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication.
    Oranje B; Glenthøj BY
    Schizophr Bull; 2014 Sep; 40(5):1022-9. PubMed ID: 24106334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.